Richard Hector

Richard Hector is the Head of Intellectual Property at Scribe Therapeutics, where he assists in most legal matters involving the company. Prior to his current role, he served as General Counsel at Amunix Pharmaceuticals, a biotechnology company focused on immuno-oncology and half-life extension products. Before joining Amunix, he was an associate in the Life Sciences patent group at Wilson Sonsini Goodrich & Rosati. In addition, Richard has held various research and management positions in the pharmaceutical industry, including at Bayer, Shaman Pharmaceuticals, and Connetics. He also served as Project Director for the Valley Fever Vaccine Project at the University of California, San Francisco. Richard received his Ph.D. in Microbiology from the University of California, Davis, and his J.D. from Golden Gate University. He is licensed to practice law in California and before the USPTO.